Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation

Tacrolimus (Tac) is a profoundly effective immunosuppressant that reduces the risk of rejection after solid organ transplantation. However, its use is hampered by its narrow therapeutic window along with its highly variable pharmacological (pharmacokinetic [PK] and pharmacodynamic [PD]) profile. Par...

Descripción completa

Detalles Bibliográficos
Autores principales: Woillard, Jean-Baptiste, Mourad, Michel, Neely, Michael, Capron, Arnaud, van Schaik, Ron H., van Gelder, Teun, Lloberas, Nuria, Hesselink, Dennis A., Marquet, Pierre, Haufroid, Vincent, Elens, Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462973/
https://www.ncbi.nlm.nih.gov/pubmed/28642710
http://dx.doi.org/10.3389/fphar.2017.00358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462973/
https://www.ncbi.nlm.nih.gov/pubmed/28642710
http://dx.doi.org/10.3389/fphar.2017.00358

Ejemplares similares